| Year |
Citation |
Score |
| 2012 |
Schmit TL, Nihal M, Ndiaye M, Setaluri V, Spiegelman VS, Ahmad N. Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis. Cancer Research. 72: 3864-72. PMID 22593191 DOI: 10.1158/0008-5472.Can-12-0714 |
0.626 |
|
| 2012 |
Wilhelm M, Kukekov NV, Schmit TL, Biagas KV, Sproul AA, Gire S, Maes ME, Xu Z, Greene LA. Sh3rf2/POSHER protein promotes cell survival by ring-mediated proteasomal degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s) protein. The Journal of Biological Chemistry. 287: 2247-56. PMID 22128169 DOI: 10.1074/Jbc.M111.269431 |
0.373 |
|
| 2011 |
Nihal M, Stutz N, Schmit T, Ahmad N, Wood GS. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Cell Cycle (Georgetown, Tex.). 10: 1303-11. PMID 21436619 DOI: 10.4161/Cc.10.8.15353 |
0.617 |
|
| 2011 |
Jung-Hynes B, Schmit TL, Reagan-Shaw SR, Siddiqui IA, Mukhtar H, Ahmad N. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. Journal of Pineal Research. 50: 140-9. PMID 21062352 DOI: 10.1111/J.1600-079X.2010.00823.X |
0.7 |
|
| 2011 |
Ledesma MC, Jung-Hynes B, Schmit TL, Kumar R, Mukhtar H, Ahmad N. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Molecular Medicine (Cambridge, Mass.). 17: 134-43. PMID 20882260 DOI: 10.2119/Molmed.2010.00136 |
0.657 |
|
| 2010 |
Schmit TL, Ledesma MC, Ahmad N. Modulating polo-like kinase 1 as a means for cancer chemoprevention. Pharmaceutical Research. 27: 989-98. PMID 20107874 DOI: 10.1007/S11095-010-0051-8 |
0.623 |
|
| 2010 |
Jung-Hynes BD, Schmit TL, Reagan-Shaw S, Siddiqui IA, Mukhtar H, Ahmad N. Abstract 5478: Melatonin, a novel Sirt1 inhibitor, imparts anti-proliferative effects against PCain vitroin cell culture andin vivoin transgenic adenocarcinoma of mouse prostate (TRAMP) model Cancer Research. 70: 5478-5478. DOI: 10.1158/1538-7445.Am10-5478 |
0.702 |
|
| 2010 |
Schmit TL, Setaluri V, Spiegelman VS, Ahmad N. Abstract 1064: Numb, a progenitor cell fate determinant and intrinsic inhibitor of Notch signaling, is cell cycle regulated and required for proper mitotic entry and progression in melanoma cells Cellular and Molecular Biology. 70: 1064-1064. DOI: 10.1158/1538-7445.Am10-1064 |
0.577 |
|
| 2010 |
Schmit TL, Setaluri V, Spiegelman VS, Ahmad N. Abstract 1062: Numb, an intrinsic Notch inhibitor, possesses a tumor suppressor role through regulation of Plk1 localization during mitosis Cancer Research. 70: 1062-1062. DOI: 10.1158/1538-7445.Am10-1062 |
0.593 |
|
| 2009 |
Schmit TL, Zhong W, Nihal M, Ahmad N. Polo-like kinase 1 (Plk1) in non-melanoma skin cancers. Cell Cycle (Georgetown, Tex.). 8: 2697-702. PMID 19652546 DOI: 10.4161/Cc.8.17.9413 |
0.649 |
|
| 2009 |
Schmit TL, Zhong W, Setaluri V, Spiegelman VS, Ahmad N. Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells. The Journal of Investigative Dermatology. 129: 2843-53. PMID 19554017 DOI: 10.1038/Jid.2009.172 |
0.642 |
|
| 2007 |
Schmit TL, Ahmad N. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Molecular Cancer Therapeutics. 6: 1920-31. PMID 17620424 DOI: 10.1158/1535-7163.Mct-06-0781 |
0.591 |
|
| Show low-probability matches. |